Interleukin-1 receptor antagonist treatment for refractory complex regional pain syndrome
Latest Information Update: 04 Mar 2024
At a glance
- Drugs Anakinra (Primary)
- Indications Pain
- Focus Adverse reactions; Therapeutic Use
- Acronyms INCA
- 13 Feb 2024 Status changed from recruiting to active, no longer recruiting.
- 13 Feb 2024 Planned End Date changed from 30 Jun 2024 to 31 Oct 2024.
- 13 Feb 2024 Status changed from active, no longer recruiting to recruiting.